Correlation Between Memphis Pharmaceuticals and Orascom Financial

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Orascom Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Orascom Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Memphis Pharmaceuticals and Orascom Financial Holding, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Orascom Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Orascom Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Orascom Financial.

Diversification Opportunities for Memphis Pharmaceuticals and Orascom Financial

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Memphis and Orascom is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Orascom Financial Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orascom Financial Holding and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Orascom Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orascom Financial Holding has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Orascom Financial go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Orascom Financial

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to generate 2.2 times more return on investment than Orascom Financial. However, Memphis Pharmaceuticals is 2.2 times more volatile than Orascom Financial Holding. It trades about 0.03 of its potential returns per unit of risk. Orascom Financial Holding is currently generating about 0.03 per unit of risk. If you would invest  6,299  in Memphis Pharmaceuticals on September 24, 2024 and sell it today you would lose (1,027) from holding Memphis Pharmaceuticals or give up 16.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Memphis Pharmaceuticals  vs.  Orascom Financial Holding

 Performance 
       Timeline  
Memphis Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Orascom Financial Holding 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Orascom Financial Holding are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Orascom Financial may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Memphis Pharmaceuticals and Orascom Financial Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Memphis Pharmaceuticals and Orascom Financial

The main advantage of trading using opposite Memphis Pharmaceuticals and Orascom Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Orascom Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orascom Financial will offset losses from the drop in Orascom Financial's long position.
The idea behind Memphis Pharmaceuticals and Orascom Financial Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum